IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
559.07
+0.27 (0.05%)
Jul 31, 2026, 4:00 PM EDT - Market closed

IDEXX Laboratories Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
200.53180.07288.27453.93112.55144.45
Cash & Short-Term Investments
200.53180.07288.27453.93112.55144.45
Cash Growth
22.30%-37.53%-36.50%303.33%-22.09%-62.38%
Accounts Receivable
603.54552.38473.58457.45400.62368.35
Inventory
382.4377.76381.88380.28367.82269.03
Other Current Assets
267.6303.62256.18203.6220.49173.82
Total Current Assets
1,4541,4141,4001,4951,101955.66
Net Property, Plant & Equipment
861.78870.61829.25817.68768.09692.77
Other Intangible Assets
104.75109.84111.6884.597.6799.04
Goodwill
412.1414405.1365.96361.8359.35
Other Long-Term Assets
552.79542.48547.52496.53417.73330.4
Total Assets
3,3853,3513,2933,2602,7472,437

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
129.97110.41114.21110.64110.22116.14
Accrued Expenses
453.55530.15502.12478.71433.66458.91
Short-Term Debt
53039825025057973.5
Current Portion of Long-Term Debt
15075167.797574.9875
Unearned Revenue
36.3335.2633.837.237.9440.03
Total Current Liabilities
1,3001,1491,068951.551,236763.58
Long-Term Debt
299.85374.84449.79622.88694.39775.21
Long-Term Leases
98.75101.1597.8499.67101.2487.38
Other Long-Term Liabilities
130.94120.5782.59101.2975.74121.05
Total Long-Term Liabilities
529.54596.56630.21823.85902.23983.63
Total Liabilities
1,8291,7451,6981,7752,1381,747

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
10.8510.8410.7810.7510.7210.69
Treasury Stock
-6,927-6,561-5,334-4,475-4,392-3,571
Additional Paid-in Capital
1,8671,8331,6801,5751,4681,383
Accumulated Other Comprehensive Income
-64.94-68.84-93.65-71.21-77.8-53.48
Retained Earnings
6,6706,3925,3324,4453,6002,920
Total Common Shareholders' Equity
1,5561,6051,5951,485608.74689.99
Shareholders' Equity
1,5561,6051,5951,485608.74689.99
Total Liabilities & Equity
3,3853,3513,2933,2602,7472,437

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,079948.99965.411,0481,4501,011
Net Cash (Debt)
-878.07-768.92-677.14-593.62-1,337-866.62
Net Cash Growth
------
Net Cash Per Share
-10.90-9.49-8.13-7.07-15.80-10.01
Book Value
1,5561,6051,5951,485608.74689.99
Book Value Per Share
19.3119.8119.1617.687.207.97
Tangible Book Value
1,0391,0821,0791,034149.27231.61
Tangible Book Value Per Share
12.9013.3512.9612.311.762.68
SEC Filings: 10-K · 10-Q